(Q48418407)

English

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

phase II clinical trial

0 references

Adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

Thomas Hundsberger

object named as

Thomas Hundsberger

8

0 references

15

object named as

Michael Weller

1 reference

Europe PubMed Central

11 February 2018

9

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

11 February 2018

Guido Reifenberger

14

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

11 February 2018

Richard Meyermann

10

object named as

Richard Meyermann

1 reference

Europe PubMed Central

11 February 2018

Rolf-Dieter Kortmann

6

object named as

Rolf-Dieter Kortmann

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Joachim Steinbach

7

object named as

Joachim P Steinbach

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Ulrich Herrlinger

1

object named as

Ulrich Herrlinger

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

author name string

Johannes Rieger

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Dorothee Koch

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Simon Loeser

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Britta Blaschke

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Ta-Chih Tan

11

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Clemens Sommer

12

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Michael Bamberg

13

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Journal of Clinical Oncology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

24

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

27

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

4412-4417

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Identifiers

10.1200/JCO.2006.06.9104

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16983109

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48418407&oldid=1859604300"